Reduction of mammalian neoplasms with phospholipase A2 activating substances
US5527775A · kind A · utility
10Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 1994 |
| Grant date | Jun 18, 1996 |
| Priority date | — |
| Expiry date | Oct 13, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating mammalian neoplastic disease are disclosed using phospholipase A.sub.2 activating proteins and fragments thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.